Pharma & Healthcare
Global Insomnia Treatment Drugs Market Research Report 2024
- Feb 19, 24
- ID: 53602
- Pages: 80
- Figures: 167
- Views: 23
Insomnia is a sleep disorder characterized by difficulty falling and/or staying asleep. Insomnia medications can improve this condition.
The global Insomnia Treatment Drugs market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 3710.3 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Insomnia Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Treatment Drugs.
Report Scope
The Insomnia Treatment Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insomnia Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insomnia Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F.Hoffman La-Roche AG
Merck & Co. Inc.
Mylan N.V.
Pfizer, Inc.
Pernix Therapeutics
Sanofi S.A.
Takeda Pharmaceutical Company Ltd.
Sumitomo Dainippon Pharma Co., Ltd
Teva Pharmaceutical Industries Ltd.
Vanda Pharmaceuticals, Inc.
Segment by Type
Prescription Sleep Aids
Over the Counter (OTC) Sleep Aids
Segment by Application
Hospital
Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insomnia Treatment Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Insomnia Treatment Drugs market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 3710.3 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Insomnia Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Treatment Drugs.
Report Scope
The Insomnia Treatment Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insomnia Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insomnia Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F.Hoffman La-Roche AG
Merck & Co. Inc.
Mylan N.V.
Pfizer, Inc.
Pernix Therapeutics
Sanofi S.A.
Takeda Pharmaceutical Company Ltd.
Sumitomo Dainippon Pharma Co., Ltd
Teva Pharmaceutical Industries Ltd.
Vanda Pharmaceuticals, Inc.
Segment by Type
Prescription Sleep Aids
Over the Counter (OTC) Sleep Aids
Segment by Application
Hospital
Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insomnia Treatment Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Treatment Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Prescription Sleep Aids
1.2.3 Over the Counter (OTC) Sleep Aids
1.3 Market by Application
1.3.1 Global Insomnia Treatment Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Treatment Drugs Market Perspective (2019-2030)
2.2 Insomnia Treatment Drugs Growth Trends by Region
2.2.1 Global Insomnia Treatment Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Insomnia Treatment Drugs Historic Market Size by Region (2019-2024)
2.2.3 Insomnia Treatment Drugs Forecasted Market Size by Region (2025-2030)
2.3 Insomnia Treatment Drugs Market Dynamics
2.3.1 Insomnia Treatment Drugs Industry Trends
2.3.2 Insomnia Treatment Drugs Market Drivers
2.3.3 Insomnia Treatment Drugs Market Challenges
2.3.4 Insomnia Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Treatment Drugs Players by Revenue
3.1.1 Global Top Insomnia Treatment Drugs Players by Revenue (2019-2024)
3.1.2 Global Insomnia Treatment Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Insomnia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Insomnia Treatment Drugs Revenue
3.4 Global Insomnia Treatment Drugs Market Concentration Ratio
3.4.1 Global Insomnia Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Treatment Drugs Revenue in 2023
3.5 Insomnia Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Insomnia Treatment Drugs Product Solution and Service
3.7 Date of Enter into Insomnia Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Treatment Drugs Breakdown Data by Type
4.1 Global Insomnia Treatment Drugs Historic Market Size by Type (2019-2024)
4.2 Global Insomnia Treatment Drugs Forecasted Market Size by Type (2025-2030)
5 Insomnia Treatment Drugs Breakdown Data by Application
5.1 Global Insomnia Treatment Drugs Historic Market Size by Application (2019-2024)
5.2 Global Insomnia Treatment Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Insomnia Treatment Drugs Market Size (2019-2030)
6.2 North America Insomnia Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Insomnia Treatment Drugs Market Size by Country (2019-2024)
6.4 North America Insomnia Treatment Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Insomnia Treatment Drugs Market Size (2019-2030)
7.2 Europe Insomnia Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Insomnia Treatment Drugs Market Size by Country (2019-2024)
7.4 Europe Insomnia Treatment Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Treatment Drugs Market Size (2019-2030)
8.2 Asia-Pacific Insomnia Treatment Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Insomnia Treatment Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Insomnia Treatment Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Insomnia Treatment Drugs Market Size (2019-2030)
9.2 Latin America Insomnia Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Insomnia Treatment Drugs Market Size by Country (2019-2024)
9.4 Latin America Insomnia Treatment Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Treatment Drugs Market Size (2019-2030)
10.2 Middle East & Africa Insomnia Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Insomnia Treatment Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Insomnia Treatment Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F.Hoffman La-Roche AG
11.1.1 F.Hoffman La-Roche AG Company Detail
11.1.2 F.Hoffman La-Roche AG Business Overview
11.1.3 F.Hoffman La-Roche AG Insomnia Treatment Drugs Introduction
11.1.4 F.Hoffman La-Roche AG Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.1.5 F.Hoffman La-Roche AG Recent Development
11.2 Merck & Co. Inc.
11.2.1 Merck & Co. Inc. Company Detail
11.2.2 Merck & Co. Inc. Business Overview
11.2.3 Merck & Co. Inc. Insomnia Treatment Drugs Introduction
11.2.4 Merck & Co. Inc. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.2.5 Merck & Co. Inc. Recent Development
11.3 Mylan N.V.
11.3.1 Mylan N.V. Company Detail
11.3.2 Mylan N.V. Business Overview
11.3.3 Mylan N.V. Insomnia Treatment Drugs Introduction
11.3.4 Mylan N.V. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.3.5 Mylan N.V. Recent Development
11.4 Pfizer, Inc.
11.4.1 Pfizer, Inc. Company Detail
11.4.2 Pfizer, Inc. Business Overview
11.4.3 Pfizer, Inc. Insomnia Treatment Drugs Introduction
11.4.4 Pfizer, Inc. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.4.5 Pfizer, Inc. Recent Development
11.5 Pernix Therapeutics
11.5.1 Pernix Therapeutics Company Detail
11.5.2 Pernix Therapeutics Business Overview
11.5.3 Pernix Therapeutics Insomnia Treatment Drugs Introduction
11.5.4 Pernix Therapeutics Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.5.5 Pernix Therapeutics Recent Development
11.6 Sanofi S.A.
11.6.1 Sanofi S.A. Company Detail
11.6.2 Sanofi S.A. Business Overview
11.6.3 Sanofi S.A. Insomnia Treatment Drugs Introduction
11.6.4 Sanofi S.A. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.6.5 Sanofi S.A. Recent Development
11.7 Takeda Pharmaceutical Company Ltd.
11.7.1 Takeda Pharmaceutical Company Ltd. Company Detail
11.7.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.7.3 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Introduction
11.7.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.7.5 Takeda Pharmaceutical Company Ltd. Recent Development
11.8 Sumitomo Dainippon Pharma Co., Ltd
11.8.1 Sumitomo Dainippon Pharma Co., Ltd Company Detail
11.8.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.8.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Introduction
11.8.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.8.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
11.9 Teva Pharmaceutical Industries Ltd.
11.9.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.9.3 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Introduction
11.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.9.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.10 Vanda Pharmaceuticals, Inc.
11.10.1 Vanda Pharmaceuticals, Inc. Company Detail
11.10.2 Vanda Pharmaceuticals, Inc. Business Overview
11.10.3 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Introduction
11.10.4 Vanda Pharmaceuticals, Inc. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.10.5 Vanda Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Treatment Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Prescription Sleep Aids
1.2.3 Over the Counter (OTC) Sleep Aids
1.3 Market by Application
1.3.1 Global Insomnia Treatment Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Treatment Drugs Market Perspective (2019-2030)
2.2 Insomnia Treatment Drugs Growth Trends by Region
2.2.1 Global Insomnia Treatment Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Insomnia Treatment Drugs Historic Market Size by Region (2019-2024)
2.2.3 Insomnia Treatment Drugs Forecasted Market Size by Region (2025-2030)
2.3 Insomnia Treatment Drugs Market Dynamics
2.3.1 Insomnia Treatment Drugs Industry Trends
2.3.2 Insomnia Treatment Drugs Market Drivers
2.3.3 Insomnia Treatment Drugs Market Challenges
2.3.4 Insomnia Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Treatment Drugs Players by Revenue
3.1.1 Global Top Insomnia Treatment Drugs Players by Revenue (2019-2024)
3.1.2 Global Insomnia Treatment Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Insomnia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Insomnia Treatment Drugs Revenue
3.4 Global Insomnia Treatment Drugs Market Concentration Ratio
3.4.1 Global Insomnia Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Treatment Drugs Revenue in 2023
3.5 Insomnia Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Insomnia Treatment Drugs Product Solution and Service
3.7 Date of Enter into Insomnia Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Treatment Drugs Breakdown Data by Type
4.1 Global Insomnia Treatment Drugs Historic Market Size by Type (2019-2024)
4.2 Global Insomnia Treatment Drugs Forecasted Market Size by Type (2025-2030)
5 Insomnia Treatment Drugs Breakdown Data by Application
5.1 Global Insomnia Treatment Drugs Historic Market Size by Application (2019-2024)
5.2 Global Insomnia Treatment Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Insomnia Treatment Drugs Market Size (2019-2030)
6.2 North America Insomnia Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Insomnia Treatment Drugs Market Size by Country (2019-2024)
6.4 North America Insomnia Treatment Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Insomnia Treatment Drugs Market Size (2019-2030)
7.2 Europe Insomnia Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Insomnia Treatment Drugs Market Size by Country (2019-2024)
7.4 Europe Insomnia Treatment Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Treatment Drugs Market Size (2019-2030)
8.2 Asia-Pacific Insomnia Treatment Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Insomnia Treatment Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Insomnia Treatment Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Insomnia Treatment Drugs Market Size (2019-2030)
9.2 Latin America Insomnia Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Insomnia Treatment Drugs Market Size by Country (2019-2024)
9.4 Latin America Insomnia Treatment Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Treatment Drugs Market Size (2019-2030)
10.2 Middle East & Africa Insomnia Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Insomnia Treatment Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Insomnia Treatment Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F.Hoffman La-Roche AG
11.1.1 F.Hoffman La-Roche AG Company Detail
11.1.2 F.Hoffman La-Roche AG Business Overview
11.1.3 F.Hoffman La-Roche AG Insomnia Treatment Drugs Introduction
11.1.4 F.Hoffman La-Roche AG Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.1.5 F.Hoffman La-Roche AG Recent Development
11.2 Merck & Co. Inc.
11.2.1 Merck & Co. Inc. Company Detail
11.2.2 Merck & Co. Inc. Business Overview
11.2.3 Merck & Co. Inc. Insomnia Treatment Drugs Introduction
11.2.4 Merck & Co. Inc. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.2.5 Merck & Co. Inc. Recent Development
11.3 Mylan N.V.
11.3.1 Mylan N.V. Company Detail
11.3.2 Mylan N.V. Business Overview
11.3.3 Mylan N.V. Insomnia Treatment Drugs Introduction
11.3.4 Mylan N.V. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.3.5 Mylan N.V. Recent Development
11.4 Pfizer, Inc.
11.4.1 Pfizer, Inc. Company Detail
11.4.2 Pfizer, Inc. Business Overview
11.4.3 Pfizer, Inc. Insomnia Treatment Drugs Introduction
11.4.4 Pfizer, Inc. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.4.5 Pfizer, Inc. Recent Development
11.5 Pernix Therapeutics
11.5.1 Pernix Therapeutics Company Detail
11.5.2 Pernix Therapeutics Business Overview
11.5.3 Pernix Therapeutics Insomnia Treatment Drugs Introduction
11.5.4 Pernix Therapeutics Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.5.5 Pernix Therapeutics Recent Development
11.6 Sanofi S.A.
11.6.1 Sanofi S.A. Company Detail
11.6.2 Sanofi S.A. Business Overview
11.6.3 Sanofi S.A. Insomnia Treatment Drugs Introduction
11.6.4 Sanofi S.A. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.6.5 Sanofi S.A. Recent Development
11.7 Takeda Pharmaceutical Company Ltd.
11.7.1 Takeda Pharmaceutical Company Ltd. Company Detail
11.7.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.7.3 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Introduction
11.7.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.7.5 Takeda Pharmaceutical Company Ltd. Recent Development
11.8 Sumitomo Dainippon Pharma Co., Ltd
11.8.1 Sumitomo Dainippon Pharma Co., Ltd Company Detail
11.8.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.8.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Introduction
11.8.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.8.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
11.9 Teva Pharmaceutical Industries Ltd.
11.9.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.9.3 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Introduction
11.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.9.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.10 Vanda Pharmaceuticals, Inc.
11.10.1 Vanda Pharmaceuticals, Inc. Company Detail
11.10.2 Vanda Pharmaceuticals, Inc. Business Overview
11.10.3 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Introduction
11.10.4 Vanda Pharmaceuticals, Inc. Revenue in Insomnia Treatment Drugs Business (2019-2024)
11.10.5 Vanda Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Insomnia Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Prescription Sleep Aids
Table 3. Key Players of Over the Counter (OTC) Sleep Aids
Table 4. Global Insomnia Treatment Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Insomnia Treatment Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Insomnia Treatment Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Insomnia Treatment Drugs Market Share by Region (2019-2024)
Table 8. Global Insomnia Treatment Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Insomnia Treatment Drugs Market Share by Region (2025-2030)
Table 10. Insomnia Treatment Drugs Market Trends
Table 11. Insomnia Treatment Drugs Market Drivers
Table 12. Insomnia Treatment Drugs Market Challenges
Table 13. Insomnia Treatment Drugs Market Restraints
Table 14. Global Insomnia Treatment Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Insomnia Treatment Drugs Market Share by Players (2019-2024)
Table 16. Global Top Insomnia Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Treatment Drugs as of 2023)
Table 17. Ranking of Global Top Insomnia Treatment Drugs Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Insomnia Treatment Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Insomnia Treatment Drugs Product Solution and Service
Table 21. Date of Enter into Insomnia Treatment Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Insomnia Treatment Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Insomnia Treatment Drugs Revenue Market Share by Type (2019-2024)
Table 25. Global Insomnia Treatment Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Insomnia Treatment Drugs Revenue Market Share by Type (2025-2030)
Table 27. Global Insomnia Treatment Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Insomnia Treatment Drugs Revenue Market Share by Application (2019-2024)
Table 29. Global Insomnia Treatment Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Insomnia Treatment Drugs Revenue Market Share by Application (2025-2030)
Table 31. North America Insomnia Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Insomnia Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Insomnia Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Insomnia Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Insomnia Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Insomnia Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Insomnia Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Insomnia Treatment Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Insomnia Treatment Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Insomnia Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Insomnia Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Insomnia Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Insomnia Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Insomnia Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Insomnia Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. F.Hoffman La-Roche AG Company Detail
Table 47. F.Hoffman La-Roche AG Business Overview
Table 48. F.Hoffman La-Roche AG Insomnia Treatment Drugs Product
Table 49. F.Hoffman La-Roche AG Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 50. F.Hoffman La-Roche AG Recent Development
Table 51. Merck & Co. Inc. Company Detail
Table 52. Merck & Co. Inc. Business Overview
Table 53. Merck & Co. Inc. Insomnia Treatment Drugs Product
Table 54. Merck & Co. Inc. Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 55. Merck & Co. Inc. Recent Development
Table 56. Mylan N.V. Company Detail
Table 57. Mylan N.V. Business Overview
Table 58. Mylan N.V. Insomnia Treatment Drugs Product
Table 59. Mylan N.V. Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 60. Mylan N.V. Recent Development
Table 61. Pfizer, Inc. Company Detail
Table 62. Pfizer, Inc. Business Overview
Table 63. Pfizer, Inc. Insomnia Treatment Drugs Product
Table 64. Pfizer, Inc. Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 65. Pfizer, Inc. Recent Development
Table 66. Pernix Therapeutics Company Detail
Table 67. Pernix Therapeutics Business Overview
Table 68. Pernix Therapeutics Insomnia Treatment Drugs Product
Table 69. Pernix Therapeutics Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 70. Pernix Therapeutics Recent Development
Table 71. Sanofi S.A. Company Detail
Table 72. Sanofi S.A. Business Overview
Table 73. Sanofi S.A. Insomnia Treatment Drugs Product
Table 74. Sanofi S.A. Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 75. Sanofi S.A. Recent Development
Table 76. Takeda Pharmaceutical Company Ltd. Company Detail
Table 77. Takeda Pharmaceutical Company Ltd. Business Overview
Table 78. Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Product
Table 79. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 80. Takeda Pharmaceutical Company Ltd. Recent Development
Table 81. Sumitomo Dainippon Pharma Co., Ltd Company Detail
Table 82. Sumitomo Dainippon Pharma Co., Ltd Business Overview
Table 83. Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Product
Table 84. Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 85. Sumitomo Dainippon Pharma Co., Ltd Recent Development
Table 86. Teva Pharmaceutical Industries Ltd. Company Detail
Table 87. Teva Pharmaceutical Industries Ltd. Business Overview
Table 88. Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Product
Table 89. Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 90. Teva Pharmaceutical Industries Ltd. Recent Development
Table 91. Vanda Pharmaceuticals, Inc. Company Detail
Table 92. Vanda Pharmaceuticals, Inc. Business Overview
Table 93. Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Product
Table 94. Vanda Pharmaceuticals, Inc. Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 95. Vanda Pharmaceuticals, Inc. Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Insomnia Treatment Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Insomnia Treatment Drugs Market Share by Type: 2023 VS 2030
Figure 3. Prescription Sleep Aids Features
Figure 4. Over the Counter (OTC) Sleep Aids Features
Figure 5. Global Insomnia Treatment Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Insomnia Treatment Drugs Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Pharmacy Case Studies
Figure 9. Others Case Studies
Figure 10. Insomnia Treatment Drugs Report Years Considered
Figure 11. Global Insomnia Treatment Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Insomnia Treatment Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Insomnia Treatment Drugs Market Share by Region: 2023 VS 2030
Figure 14. Global Insomnia Treatment Drugs Market Share by Players in 2023
Figure 15. Global Top Insomnia Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Treatment Drugs as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Insomnia Treatment Drugs Revenue in 2023
Figure 17. North America Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Insomnia Treatment Drugs Market Share by Country (2019-2030)
Figure 19. United States Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Insomnia Treatment Drugs Market Share by Country (2019-2030)
Figure 23. Germany Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Insomnia Treatment Drugs Market Share by Region (2019-2030)
Figure 31. China Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Insomnia Treatment Drugs Market Share by Country (2019-2030)
Figure 39. Mexico Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Insomnia Treatment Drugs Market Share by Country (2019-2030)
Figure 43. Turkey Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. F.Hoffman La-Roche AG Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 46. Merck & Co. Inc. Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 47. Mylan N.V. Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 48. Pfizer, Inc. Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 49. Pernix Therapeutics Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 50. Sanofi S.A. Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 51. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 52. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 53. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 54. Vanda Pharmaceuticals, Inc. Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Table 1. Global Insomnia Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Prescription Sleep Aids
Table 3. Key Players of Over the Counter (OTC) Sleep Aids
Table 4. Global Insomnia Treatment Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Insomnia Treatment Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Insomnia Treatment Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Insomnia Treatment Drugs Market Share by Region (2019-2024)
Table 8. Global Insomnia Treatment Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Insomnia Treatment Drugs Market Share by Region (2025-2030)
Table 10. Insomnia Treatment Drugs Market Trends
Table 11. Insomnia Treatment Drugs Market Drivers
Table 12. Insomnia Treatment Drugs Market Challenges
Table 13. Insomnia Treatment Drugs Market Restraints
Table 14. Global Insomnia Treatment Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Insomnia Treatment Drugs Market Share by Players (2019-2024)
Table 16. Global Top Insomnia Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Treatment Drugs as of 2023)
Table 17. Ranking of Global Top Insomnia Treatment Drugs Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Insomnia Treatment Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Insomnia Treatment Drugs Product Solution and Service
Table 21. Date of Enter into Insomnia Treatment Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Insomnia Treatment Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Insomnia Treatment Drugs Revenue Market Share by Type (2019-2024)
Table 25. Global Insomnia Treatment Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Insomnia Treatment Drugs Revenue Market Share by Type (2025-2030)
Table 27. Global Insomnia Treatment Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Insomnia Treatment Drugs Revenue Market Share by Application (2019-2024)
Table 29. Global Insomnia Treatment Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Insomnia Treatment Drugs Revenue Market Share by Application (2025-2030)
Table 31. North America Insomnia Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Insomnia Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Insomnia Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Insomnia Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Insomnia Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Insomnia Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Insomnia Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Insomnia Treatment Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Insomnia Treatment Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Insomnia Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Insomnia Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Insomnia Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Insomnia Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Insomnia Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Insomnia Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. F.Hoffman La-Roche AG Company Detail
Table 47. F.Hoffman La-Roche AG Business Overview
Table 48. F.Hoffman La-Roche AG Insomnia Treatment Drugs Product
Table 49. F.Hoffman La-Roche AG Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 50. F.Hoffman La-Roche AG Recent Development
Table 51. Merck & Co. Inc. Company Detail
Table 52. Merck & Co. Inc. Business Overview
Table 53. Merck & Co. Inc. Insomnia Treatment Drugs Product
Table 54. Merck & Co. Inc. Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 55. Merck & Co. Inc. Recent Development
Table 56. Mylan N.V. Company Detail
Table 57. Mylan N.V. Business Overview
Table 58. Mylan N.V. Insomnia Treatment Drugs Product
Table 59. Mylan N.V. Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 60. Mylan N.V. Recent Development
Table 61. Pfizer, Inc. Company Detail
Table 62. Pfizer, Inc. Business Overview
Table 63. Pfizer, Inc. Insomnia Treatment Drugs Product
Table 64. Pfizer, Inc. Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 65. Pfizer, Inc. Recent Development
Table 66. Pernix Therapeutics Company Detail
Table 67. Pernix Therapeutics Business Overview
Table 68. Pernix Therapeutics Insomnia Treatment Drugs Product
Table 69. Pernix Therapeutics Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 70. Pernix Therapeutics Recent Development
Table 71. Sanofi S.A. Company Detail
Table 72. Sanofi S.A. Business Overview
Table 73. Sanofi S.A. Insomnia Treatment Drugs Product
Table 74. Sanofi S.A. Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 75. Sanofi S.A. Recent Development
Table 76. Takeda Pharmaceutical Company Ltd. Company Detail
Table 77. Takeda Pharmaceutical Company Ltd. Business Overview
Table 78. Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Product
Table 79. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 80. Takeda Pharmaceutical Company Ltd. Recent Development
Table 81. Sumitomo Dainippon Pharma Co., Ltd Company Detail
Table 82. Sumitomo Dainippon Pharma Co., Ltd Business Overview
Table 83. Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Product
Table 84. Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 85. Sumitomo Dainippon Pharma Co., Ltd Recent Development
Table 86. Teva Pharmaceutical Industries Ltd. Company Detail
Table 87. Teva Pharmaceutical Industries Ltd. Business Overview
Table 88. Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Product
Table 89. Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 90. Teva Pharmaceutical Industries Ltd. Recent Development
Table 91. Vanda Pharmaceuticals, Inc. Company Detail
Table 92. Vanda Pharmaceuticals, Inc. Business Overview
Table 93. Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Product
Table 94. Vanda Pharmaceuticals, Inc. Revenue in Insomnia Treatment Drugs Business (2019-2024) & (US$ Million)
Table 95. Vanda Pharmaceuticals, Inc. Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Insomnia Treatment Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Insomnia Treatment Drugs Market Share by Type: 2023 VS 2030
Figure 3. Prescription Sleep Aids Features
Figure 4. Over the Counter (OTC) Sleep Aids Features
Figure 5. Global Insomnia Treatment Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Insomnia Treatment Drugs Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Pharmacy Case Studies
Figure 9. Others Case Studies
Figure 10. Insomnia Treatment Drugs Report Years Considered
Figure 11. Global Insomnia Treatment Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Insomnia Treatment Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Insomnia Treatment Drugs Market Share by Region: 2023 VS 2030
Figure 14. Global Insomnia Treatment Drugs Market Share by Players in 2023
Figure 15. Global Top Insomnia Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Treatment Drugs as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Insomnia Treatment Drugs Revenue in 2023
Figure 17. North America Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Insomnia Treatment Drugs Market Share by Country (2019-2030)
Figure 19. United States Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Insomnia Treatment Drugs Market Share by Country (2019-2030)
Figure 23. Germany Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Insomnia Treatment Drugs Market Share by Region (2019-2030)
Figure 31. China Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Insomnia Treatment Drugs Market Share by Country (2019-2030)
Figure 39. Mexico Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Insomnia Treatment Drugs Market Share by Country (2019-2030)
Figure 43. Turkey Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Insomnia Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. F.Hoffman La-Roche AG Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 46. Merck & Co. Inc. Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 47. Mylan N.V. Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 48. Pfizer, Inc. Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 49. Pernix Therapeutics Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 50. Sanofi S.A. Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 51. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 52. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 53. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 54. Vanda Pharmaceuticals, Inc. Revenue Growth Rate in Insomnia Treatment Drugs Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Food Grade FIBC Bulk Bags Market Research Report 2025
Jan 09, 25
Global Standard FIBC Market Research Report 2025
Jan 09, 25
Global Mammoplasty Retractors Market Research Report 2025
Jan 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232